Literature DB >> 35829

beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated.

K P Minneman, M D Dibner, B B Wolfe, P B Molinoff.   

Abstract

Repeated administration of the tricyclic antidepressant desmethylimipramine to adult rats for 10 days caused a 40% decrease in the density of beta1-adrenergic receptors in the cerebral cortex but had no effect on the density of beta2-adrenergic receptors. Conversely, destruction of noradrenergic neurons by administration of 6-hydroxydopamine to neonatal rats caused a 64% increase in the density of beta1-adrenergic receptors in adult cerebral cortex with no change in the density of beta2-adrenergic receptors. These results suggest that the beta-adrenergic receptors in rat cortex involved in neuronal function are primarily of the beta1 subtype.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35829     DOI: 10.1126/science.35829

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment.

Authors:  F De Paermentier; S C Cheetham; M R Crompton; C L Katona; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Measuring the activity of brain adrenergic receptors in man.

Authors:  S al-Damluji
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

3.  Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neocortical explants is seen only with the beta-1, not with the beta-2 subtype.

Authors:  G J Boer; A A Kellerman; R E Baker; P te Riele; M G Feenstra; M Botterblom; B H Erdtsieck-Ernste
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

4.  Modulation of desynchronized sleep through microinjection of beta-adrenergic agonists and antagonists in the dorsal pontine tegmentum of the cat.

Authors:  G Tononi; M Pompeiano; O Pompeiano
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

5.  Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior.

Authors:  A V Vergoni; A Forgione; A Bertolini
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

6.  Effects of salbutamol upon performance on an operant screen for antidepressants.

Authors:  R T Dunn; J B Richards; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Beta-receptor responsiveness after desipramine treatment.

Authors:  R Pohl; G N Pandey; V K Yeragani; R Balon; J M Davis; R Berchou
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Blockade of beta 1- but not of beta 2-adrenergic receptors replicates propranolol's suppression of the cerebral spread of an engram in mice.

Authors:  J B Flexner; L B Flexner; A C Church; T C Rainbow; D J Brunswick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Reduced brain serotonergic activity after repeated treatment with beta-adrenoceptor antagonists.

Authors:  H Hallberg; O Almgren; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Development of and recovery from subsensitivity of the noradrenergic cyclic AMP generating system in brain. Effect of amphetamine following inhibition of its aromatic hydroxylation by iprindole.

Authors:  D H Manier; D D Gillespie; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.